B-cell Maturation Antigen-Targeted Autologous CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma

SCCA’s Andrew J. Cowan spoke to Cancer Therapy Advisor about CART-cell therapy for relapsed, refractory multiple myeloma.

Read the article